Support for an advantage of intraperitoneal (IP) cisplatin (DDP) therapy (RX) over continued intravenous (IV) cisplatin in patients with residual ovarian-carcinoma (ROC) Meeting Abstract
| Authors: | Markman, M.; Hakes, T.; Reichman, B. |
| Abstract Title: | Support for an advantage of intraperitoneal (IP) cisplatin (DDP) therapy (RX) over continued intravenous (IV) cisplatin in patients with residual ovarian-carcinoma (ROC) |
| Meeting Title: | 1989 Annual Meeting of the American Federation for Clinical Research - Eastern Section |
| Journal Title: | Clinical Research |
| Volume: | 37 |
| Issue: | 3 |
| Meeting Dates: | 1989 Sep 22-23 |
| Meeting Location: | New York, NY |
| ISSN: | 0009-9279 |
| Publisher: | SLACK, Inc. |
| Date Published: | 1989-09-01 |
| Start Page: | 861A |
| Language: | English |
| ACCESSION: | WOS:A1989AN30100173 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
